Brain Metastases News and Research

RSS
Alecensa (alectinib) approved for treatment of people with advanced ALK-positive NSCLC

Alecensa (alectinib) approved for treatment of people with advanced ALK-positive NSCLC

AstraZeneca announces FDA approval of TAGRISSO (AZD9291) for treatment of lung cancer patients

AstraZeneca announces FDA approval of TAGRISSO (AZD9291) for treatment of lung cancer patients

Discovery may lead to new anti-metastasis therapies for advanced-stage brain cancer patients

Discovery may lead to new anti-metastasis therapies for advanced-stage brain cancer patients

Rare genetic mutation could improve outcomes in NSCLC patients with brain metastases

Rare genetic mutation could improve outcomes in NSCLC patients with brain metastases

Brain metastases evolve ‘clinically actionable’ mutations

Brain metastases evolve ‘clinically actionable’ mutations

Certain laboratory results can help to predict survival in patients with brain metastases

Certain laboratory results can help to predict survival in patients with brain metastases

CRI commits $29.3 million in new funds to accelerate development of cancer immunotherapies

CRI commits $29.3 million in new funds to accelerate development of cancer immunotherapies

ASCO 2015: Novartis presents data on Zykadia and Tafinlar studies for non-small cell lung cancer

ASCO 2015: Novartis presents data on Zykadia and Tafinlar studies for non-small cell lung cancer

WBRT associated with worse cognitive function than radiosurgery, shows study

WBRT associated with worse cognitive function than radiosurgery, shows study

Investigational anti-cancer agent ONT-380 shows activity against HER2+ breast cancer

Investigational anti-cancer agent ONT-380 shows activity against HER2+ breast cancer

Mirati Therapeutics presents preliminary results of MGCD265 tyrosine kinase inhibitor at ASCO 2015

Mirati Therapeutics presents preliminary results of MGCD265 tyrosine kinase inhibitor at ASCO 2015

Caris Molecular Intelligence allows comparisons between tumors sharing histological features

Caris Molecular Intelligence allows comparisons between tumors sharing histological features

Brigatinib drug shows promise against ALK+ non-small cell lung cancer in phase I/II clinical trial

Brigatinib drug shows promise against ALK+ non-small cell lung cancer in phase I/II clinical trial

Blood-thinning treatment safe for patients with brain metastases

Blood-thinning treatment safe for patients with brain metastases

Study analyzes outcomes of brain metastases patients following stereotactic radiosurgery

Study analyzes outcomes of brain metastases patients following stereotactic radiosurgery

Researchers show potential of stem cell-based therapy in treating brain-metastatic breast cancer

Researchers show potential of stem cell-based therapy in treating brain-metastatic breast cancer

SRS fails to improve survival for NSCLC brain metastases patients

SRS fails to improve survival for NSCLC brain metastases patients

UT Southwestern researchers find new potential target for halting tumor growth

UT Southwestern researchers find new potential target for halting tumor growth

Preclinical study strongly supports NT-113 as potential new treatment for glioblastoma multiforme

Preclinical study strongly supports NT-113 as potential new treatment for glioblastoma multiforme

CCR5 receptor plays key role in driving prostate cancer metastases

CCR5 receptor plays key role in driving prostate cancer metastases